{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:53:43Z","timestamp":1792292023828,"version":"4.4.0"},"reference-count":194,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2019,3,23]],"date-time":"2019-03-23T00:00:00Z","timestamp":1553299200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>In the sanctity of pure drug discovery, objective reasoning can become clouded when pursuing ideas that appear unorthodox, but are spot on physiologically. To put this into historical perspective, it was an unorthodox idea in the 1950\u2019s to suggest that warfarin, a rat poison, could be repositioned into a breakthrough drug in humans to protect against strokes as a blood thinner. Yet it was approved in 1954 as Coumadin\u00ae and has been prescribed to billions of patients as a standard of care. Similarly, no one can forget the horrific effects of thalidomide, prescribed or available without a prescription, as both a sleeping pill and \u201cmorning sickness\u201d anti-nausea medication targeting pregnant women in the 1950\u2019s. The \u201cthalidomide babies\u201d became the case-in-point for the need of strict guidelines by the U.S. Food &amp; Drug Administration (FDA) or full multi-species teratogenicity testing before drug approval. More recently it was found that thalidomide is useful in graft versus host disease, leprosy and resistant tuberculosis treatment, and as an anti-angiogenesis agent as a breakthrough drug for multiple myeloma (except for pregnant female patients). Decades of diabetes drug discovery research has historically focused on every possible angle, except, the energy-out side of the equation, namely, raising mitochondrial energy expenditure with chemical uncouplers. The idea of \u201csocial responsibility\u201d allowed energy-in agents to be explored and the portfolio is robust with medicines of insulin sensitizers, insulin analogues, secretagogues, SGLT2 inhibitors, etc., but not energy-out medicines. The primary reason? It appeared unorthodox, to return to exploring a drug platform used in the 1930s in over 100,000 obese patients used for weight loss. This is over 80-years ago and prior to Dr Peter Mitchell explaining the mechanism of how mitochondrial uncouplers, like 2,4-dinitrophenol (DNP) even worked by three decades later in 1961. Although there is a clear application for metabolic disease, it was not until recently that this platform was explored for its merit at very low, weight-neutral doses, for treating insidious human illnesses and completely unrelated to weight reduction. It is known that mitochondrial uncouplers specifically target the entire organelle\u2019s physiology non-genomically. It has been known for years that many neuromuscular and neurodegenerative diseases are associated with overt production of reactive oxygen species (ROSs), a rise in isoprostanes (biomarker of mitochondrial ROSs in urine or blood) and poor calcium (Ca2+) handing. It has also been known that mitochondrial uncouplers lower ROS production and Ca2+ overload. There is evidence that elevation of isoprostanes precedes disease onset, in Alzheimer\u2019s Disease (AD). It is also curious, why so many neurodegenerative diseases of known and unknown etiology start at mid-life or later, such as Multiple Sclerosis (MS), Huntington Disease (HD), AD, Parkinson Disease, and Amyotrophic Lateral Sclerosis (ALS). Is there a relationship to a buildup of mutations that are sequestered over time due to ROSs exceeding the rate of repair? If ROS production were managed, could disease onset due to aging be delayed or prevented? Is it possible that most, if not all neurodegenerative diseases are manifested through mitochondrial dysfunction? Although DNP, a historic mitochondrial uncoupler, was used in the 1930s at high doses for obesity in well over 100,000 humans, and so far, it has never been an FDA-approved drug. This review will focus on the application of using DNP, but now, repositioned as a potential disease-modifying drug for a legion of insidious diseases at much lower and paradoxically, weight neutral doses. DNP will be addressed as a treatment for \u201cmetabesity\u201d, an emerging term related to the global comorbidities associated with the over-nutritional phenotype; obesity, diabetes, nonalcoholic steatohepatitis (NASH), metabolic syndrome, cardiovascular disease, but including neurodegenerative disorders and accelerated aging. Some unexpected drug findings will be discussed, such as DNP\u2019s induction of neurotrophic growth factors involved in neuronal heath, learning and cognition. For the first time in 80\u2019s years, the FDA has granted (to Mitochon Pharmaceutical, Inc., Blue Bell, PA, USA) an open Investigational New Drug (IND) approval to begin rigorous clinical testing of DNP for safety and tolerability, including for the first ever, pharmacokinetic profiling in humans. Successful completion of Phase I clinical trial will open the door to explore the merits of DNP as a possible treatment of people with many truly unmet medical needs, including those suffering from HD, MS, PD, AD, ALS, Duchenne Muscular Dystrophy (DMD), and Traumatic Brain Injury (TBI).<\/jats:p>","DOI":"10.3390\/cells8030280","type":"journal-article","created":{"date-parts":[[2019,3,27]],"date-time":"2019-03-27T05:03:12Z","timestamp":1553662992000},"page":"280","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":95,"title":["2,4 Dinitrophenol as Medicine"],"prefix":"10.3390","volume":"8","author":[{"given":"John G.","family":"Geisler","sequence":"first","affiliation":[{"name":"Mitochon Pharmaceuticals, Inc., 970 Cross Lane, Blue Bell, PA 19422, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,3,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"19062","DOI":"10.1074\/jbc.M212661200","article-title":"The relationship between free and total calcium concentrations in the matrix of liver and brain mitochondria","volume":"278","author":"Chalmers","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00125-010-1932-4","article-title":"Targeting energy expenditure via fuel switching and beyond","volume":"54","author":"Geisler","year":"2011","journal-title":"Diabetologia"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1089\/ars.2009.2392","article-title":"Cross-talk between mitochondria and NADPH oxidase: Effects of mild mitochondrial dysfunction on angiotensin II-mediated increase in Nox isoform expression and activity in vascular smooth muscle cells","volume":"11","author":"Wosniak","year":"2009","journal-title":"Antioxid. Redox Signal."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1126\/science.2814477","article-title":"Human cells lacking mtDNA: Repopulation with exogenous mitochondria by complementation","volume":"246","author":"King","year":"1989","journal-title":"Science"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.taap.2003.12.001","article-title":"The effects of ethidium bromide induced loss of mitochondrial DNA on mitochondrial phenotype and ultrastructure in a human leukemia T-cell line (MOLT-4 cells)","volume":"196","author":"Armand","year":"2004","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_6","first-page":"R1213","article-title":"Causes of differences in respiration rate of hepatocytes from mammals of different body mass","volume":"269","author":"Porter","year":"1995","journal-title":"Am. J. Physiol."},{"key":"ref_7","first-page":"73","article-title":"Mitochondria-Associated Membranes and ER Stress","volume":"414","author":"Agostinis","year":"2018","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"8765","DOI":"10.1007\/s12035-018-1028-6","article-title":"The Endoplasmic Reticulum Stress Response in Neuroprogressive Diseases: Emerging Pathophysiological Role and Translational Implications","volume":"55","author":"Morris","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.brainres.2017.03.018","article-title":"Neuroprotective effects of 2,4-dinitrophenol in an acute model of Parkinson\u2019s disease","volume":"1663","author":"Lee","year":"2017","journal-title":"Brain Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1089\/neu.2011.1755","article-title":"Post-injury administration of the mitochondrial permeability transition pore inhibitor, NIM811, is neuroprotective and improves cognition after traumatic brain injury in rats","volume":"28","author":"Readnower","year":"2011","journal-title":"J. Neurotrauma"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/nm1736","article-title":"Genetic and pharmacologic inhibition of mitochondrial-dependent necrosis attenuates muscular dystrophy","volume":"14","author":"Millay","year":"2008","journal-title":"Nat. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nn884","article-title":"Early mitochondrial calcium defects in Huntington\u2019s disease are a direct effect of polyglutamines","volume":"5","author":"Panov","year":"2002","journal-title":"Nat. Neurosci."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.mito.2011.04.004","article-title":"Mitochondrial dysfunction in epilepsy","volume":"12","author":"Folbergrova","year":"2012","journal-title":"Mitochondrion"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"H767","DOI":"10.1152\/ajpheart.00700.2012","article-title":"L-type Ca(2+) channel contributes to alterations in mitochondrial calcium handling in the mdx ventricular myocyte","volume":"304","author":"Viola","year":"2013","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"923","DOI":"10.2337\/db13-0717","article-title":"beta-cell dysfunction due to increased ER stress in a stem cell model of Wolfram syndrome","volume":"63","author":"Shang","year":"2014","journal-title":"Diabetes"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"4447","DOI":"10.1073\/pnas.0307156101","article-title":"Percolation and criticality in a mitochondrial network","volume":"101","author":"Aon","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.bbalip.2014.10.007","article-title":"The isoprostanes\u201425 years later","volume":"1851","author":"Milne","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.biochi.2012.09.017","article-title":"F(2)-Dihomo-isoprostanes and brain white matter damage in stage 1 Rett syndrome","volume":"95","author":"Durand","year":"2013","journal-title":"Biochimie"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jns.2010.09.017","article-title":"Oxidative stress in children affected by epileptic encephalopathies","volume":"300","author":"Grosso","year":"2011","journal-title":"J. Neurol. Sci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.braindev.2007.11.005","article-title":"Isoprostanes in dystrophinopathy: Evidence of increased oxidative stress","volume":"30","author":"Grosso","year":"2008","journal-title":"Brain Dev."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.brainresbull.2004.04.016","article-title":"Increased urinary F(2)-isoprostanes levels in the patients with Alzheimer\u2019s disease","volume":"64","author":"Kim","year":"2004","journal-title":"Brain Res. Bull."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"F1198","DOI":"10.1152\/ajprenal.00327.2014","article-title":"Endothelial dysfunction and oxidative stress in polycystic kidney disease","volume":"307","author":"Klawitter","year":"2014","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3389\/fnagi.2017.00089","article-title":"Increased Oxidative Stress Markers in Cerebrospinal Fluid from Healthy Subjects with Parkinson\u2019s Disease-Associated LRRK2 Gene Mutations","volume":"9","author":"Loeffler","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"195935","DOI":"10.1155\/2014\/195935","article-title":"Redox imbalance and morphological changes in skin fibroblasts in typical Rett syndrome","volume":"2014","author":"Signorini","year":"2014","journal-title":"Oxid. Med. Cell Longev."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1080\/15216540600702198","article-title":"Novel neuroprotective, neuritogenic and anti-amyloidogenic properties of 2,4-dinitrophenol: The gentle face of Janus","volume":"58","author":"Ferreira","year":"2006","journal-title":"IUBMB Life"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1096\/fj.05-3812com","article-title":"Neuritogenesis and neuronal differentiation promoted by 2,4-dinitrophenol, a novel anti-amyloidogenic compound","volume":"19","author":"Silveira","year":"2005","journal-title":"FASEB J."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s12640-009-9133-y","article-title":"Expression profile of rat hippocampal neurons treated with the neuroprotective compound 2,4-dinitrophenol: Up-regulation of cAMP signaling genes","volume":"18","author":"Sebollela","year":"2010","journal-title":"Neurotox. Res."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Hubbard, W.B., Harwood, C.L., Geisler, J.G., Vekaria, H.J., and Sullivan, P.G. (2018). Mitochondrial uncoupling prodrug improves tissue sparing, cognitive outcome, and mitochondrial bioenergetics after traumatic brain injury in male mice. J. Neurosci. Res.","DOI":"10.1002\/jnr.24271"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1089\/neu.2006.3673","article-title":"Post-Injury Administration of Mitochondrial Uncouplers Increases Tissue Sparing and Improves Behavioral Outcome following Traumatic Brain Injury in Rodents","volume":"24","author":"Pandya","year":"2007","journal-title":"J. Neurotrauma"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/jnc.13176","article-title":"The mitochondrial uncoupler DNP triggers brain cell mTOR signaling network reprogramming and CREB pathway up-regulation","volume":"134","author":"Liu","year":"2015","journal-title":"J. Neurochem."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1126\/science.1067020","article-title":"The molecular biology of memory storage: A dialogue between genes and synapses","volume":"294","author":"Kandel","year":"2001","journal-title":"Science"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.cell.2014.03.001","article-title":"The molecular and systems biology of memory","volume":"157","author":"Kandel","year":"2014","journal-title":"Cell"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1749-6632.2010.05627.x","article-title":"Animal and human studies with the mitochondria-targeted antioxidant MitoQ","volume":"1201","author":"Smith","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_34","unstructured":"Sood, B., and Whitten, R. (2018). Coenzyme Q10, StatPearls."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1042\/bst0311300","article-title":"Mitochondrial matrix reactive oxygen species production is very sensitive to mild uncoupling","volume":"31","author":"Miwa","year":"2003","journal-title":"Biochem. Soc. Trans."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.freeradbiomed.2009.05.004","article-title":"Mitochondria and reactive oxygen species","volume":"47","author":"Kowaltowski","year":"2009","journal-title":"Free Radic. Biol. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"C1380","DOI":"10.1152\/ajpcell.1996.271.4.C1380","article-title":"Contribution of mitochondrial proton leak to skeletal muscle respiration and to standard metabolic rate","volume":"271","author":"Rolfe","year":"1996","journal-title":"Am. J. Physiol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1001\/jama.1933.02740520009003","article-title":"Metabolic actions of dinitrophenol with the use of balanced and unbalanced diets","volume":"101","author":"Cutting","year":"1933","journal-title":"J. Am. Med. Assoc."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"227s","DOI":"10.1083\/jcb.91.3.227s","article-title":"Mitochondria: A historical review","volume":"91","author":"Ernster","year":"1981","journal-title":"J. Cell Biol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1474-9726.2008.00407.x","article-title":"Mild mitochondrial uncoupling in mice affects energy metabolism, redox balance and longevity","volume":"7","author":"Cerqueira","year":"2008","journal-title":"Aging Cell"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1093\/hmg\/dds040","article-title":"Targeting the UPR transcription factor XBP1 protects against Huntington\u2019s disease through the regulation of FoxO1 and autophagy","volume":"21","author":"Vidal","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.tem.2015.06.001","article-title":"SIRT3 regulates progression and development of diseases of aging","volume":"26","author":"McDonnell","year":"2015","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Hershey, T., Lugar, H.M., Shimony, J.S., Rutlin, J., Koller, J.M., Perantie, D.C., Paciorkowski, A.R., Eisenstein, S.A., Permutt, M.A., and Washington University Wolfram Study, G. (2012). Early brain vulnerability in Wolfram syndrome. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0040604"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.mehy.2015.08.015","article-title":"Revisiting the dystrophin-ATP connection: How half a century of research still implicates mitochondrial dysfunction in Duchenne Muscular Dystrophy aetiology","volume":"85","author":"Timpani","year":"2015","journal-title":"Med. Hypotheses"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"32345","DOI":"10.1074\/jbc.M313478200","article-title":"Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease","volume":"279","author":"Samuel","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1111\/bph.12468","article-title":"Targeting mitochondrial cardiolipin and the cytochrome c\/cardiolipin complex to promote electron transport and optimize mitochondrial ATP synthesis","volume":"171","author":"Birk","year":"2014","journal-title":"Br. J. Pharm."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Cao, Y., Staropoli, J.F., Biswas, S., Espinola, J.A., Macdonald, M.E., Lee, J.M., and Cotman, S.L. (2011). Distinct early molecular responses to mutations causing vLINCL and JNCL presage ATP synthase subunit C accumulation in cerebellar cells. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0017118"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1083\/jcb.201011068","article-title":"Culling sick mitochondria from the herd","volume":"191","author":"Pallanck","year":"2011","journal-title":"J. Cell Biol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.bbabio.2005.11.005","article-title":"Dinitrophenol-induced mitochondrial uncoupling in vivo triggers respiratory adaptation in HepG2 cells","volume":"1757","author":"Desquiret","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1016\/j.bbadis.2014.05.035","article-title":"Role of soluble adenylyl cyclase in mitochondria","volume":"1842","author":"Valsecchi","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2174\/156720507781077287","article-title":"Cyclic AMP enhancers and Abeta oligomerization blockers as potential therapeutic agents in Alzheimer\u2019s disease","volume":"4","author":"Barbosa","year":"2007","journal-title":"Curr. Alzheimer Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.jalz.2016.08.001","article-title":"DNP, mitochondrial uncoupling, and neuroprotection: A little dab\u2019ll do ya","volume":"13","author":"Geisler","year":"2017","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/jnr.21139","article-title":"Mouse and rat BDNF gene structure and expression revisited","volume":"85","author":"Aid","year":"2007","journal-title":"J. Neurosci. Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0165-3806(94)00220-T","article-title":"Brain-derived neurotrophic factor (BDNF) can prevent apoptosis of rat cerebellar granule neurons in culture","volume":"85","author":"Kubo","year":"1995","journal-title":"Brain Res. Dev. Brain Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/08977190410001723308","article-title":"Brain-derived neurotrophic factor","volume":"22","author":"Binder","year":"2004","journal-title":"Growth Factors"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Alvarez, X.A., Alvarez, I., Iglesias, O., Crespo, I., Figueroa, J., Aleixandre, M., Linares, C., Granizo, E., Garcia-Fantini, M., and Marey, J. (2016). Synergistic Increase of Serum BDNF in Alzheimer Patients Treated with Cerebrolysin and Donepezil: Association with Cognitive Improvement in ApoE4 Cases. Int. J. Neuropsychopharmacol.","DOI":"10.1093\/ijnp\/pyw024"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/978-1-4757-6376-8_3","article-title":"The role of BDNF in epilepsy and other diseases of the mature nervous system","volume":"548","author":"Binder","year":"2004","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1073\/pnas.0536856100","article-title":"Dietary restriction normalizes glucose metabolism and BDNF levels, slows disease progression, and increases survival in huntingtin mutant mice","volume":"100","author":"Duan","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.expneurol.2007.10.015","article-title":"The antidepressant sertraline improves the phenotype, promotes neurogenesis and increases BDNF levels in the R6\/2 Huntington\u2019s disease mouse model","volume":"210","author":"Peng","year":"2008","journal-title":"Exp. Neurol."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Wysokinski, A. (2015). Serum levels of brain-derived neurotrophic factor (BDNF) and neurotrophin-3 (NT-3) in depressed patients with schizophrenia. Nord. J. Psychiatry.","DOI":"10.3109\/08039488.2015.1087592"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3389\/fnbeh.2014.00417","article-title":"Relationships between brain-derived neurotrophic factor, clinical symptoms, and decision-making in chronic schizophrenia: Data from the Iowa Gambling Task","volume":"8","author":"Hori","year":"2014","journal-title":"Front. Behav. Neurosci."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1093\/hmg\/ddt098","article-title":"Small-molecule TrkB receptor agonists improve motor function and extend survival in a mouse model of Huntington\u2019s disease","volume":"22","author":"Jiang","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"ref_63","first-page":"129","article-title":"Brain-Derived Neurotrophic Factor in children with Autism Spectrum Disorder","volume":"21","author":"Kasarpalkar","year":"2014","journal-title":"Ann. Neurosci."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"358","DOI":"10.2337\/dc11-1295","article-title":"Circulating brain-derived neurotrophic factor concentration is downregulated by intralipid\/heparin infusion or high-fat meal in young healthy male subjects","volume":"35","author":"Kowalska","year":"2012","journal-title":"Diabetes Care"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.clinbiochem.2011.05.008","article-title":"Decreased serum brain-derived neurotrophic factor concentration in young nonobese subjects with low insulin sensitivity","volume":"44","author":"Straczkowski","year":"2011","journal-title":"Clin. Biochem."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1006\/exnr.2002.8011","article-title":"Elevated levels of neurotrophins in human biceps brachii tissue of amyotrophic lateral sclerosis","volume":"177","author":"Kust","year":"2002","journal-title":"Exp. Neurol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1006\/bbrc.1997.7220","article-title":"Brain-derived neurotrophic factor reduces blood glucose level in obese diabetic mice but not in normal mice","volume":"238","author":"Ono","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"588","DOI":"10.2337\/diabetes.48.3.588","article-title":"Brain-derived neurotrophic factor improves blood glucose control and alleviates fasting hyperglycemia in C57BLKS-Lepr(db)\/lepr(db) mice","volume":"48","author":"Tonra","year":"1999","journal-title":"Diabetes"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jdiacomp.2015.01.014","article-title":"Brain-derived neurotrophic factor correlated with muscle strength in subjects undergoing stationary bicycle exercise training","volume":"29","author":"Tsai","year":"2015","journal-title":"J. Diabetes Its Complicat."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1046\/j.1463-1326.2002.00206.x","article-title":"Brain-derived neurotrophic factor ameliorates lipid metabolism in diabetic mice","volume":"4","author":"Tsuchida","year":"2002","journal-title":"Diabetes Obes. Metab."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1038\/sj.ijo.0801678","article-title":"Acute effects of brain-derived neurotrophic factor on energy expenditure in obese diabetic mice","volume":"25","author":"Tsuchida","year":"2001","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.metabol.2006.04.017","article-title":"Protective effect of brain-derived neurotrophic factor on pancreatic islets in obese diabetic mice","volume":"55","author":"Yamanaka","year":"2006","journal-title":"Metab. Clin. Exp."},{"key":"ref_73","first-page":"201","article-title":"Brain-derived neurotrophic factor regulates energy expenditure through the central nervous system in obese diabetic mice","volume":"2","author":"Nonomura","year":"2001","journal-title":"Int. J. Exp. Diabetes Res."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"436","DOI":"10.2337\/diabetes.49.3.436","article-title":"Brain-derived neurotrophic factor regulates glucose metabolism by modulating energy balance in diabetic mice","volume":"49","author":"Nakagawa","year":"2000","journal-title":"Diabetes"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1001\/jama.1933.02740280013006","article-title":"Actions and Uses of Dinitrophenol","volume":"101","author":"Cutting","year":"1933","journal-title":"JAMA"},{"key":"ref_76","first-page":"187","article-title":"Miscellaneous actions of dinitrophenol. Repeated administrations, antidotes, fatal doses, antiseptic tests and actions of some isomers","volume":"49","author":"Tainter","year":"1933","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1001\/jama.1933.02740440032009","article-title":"Use of dinitrophenol in obesity and related conditions. A progress report","volume":"101","author":"Tainter","year":"1933","journal-title":"JAMA"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.2105\/AJPH.24.10.1045","article-title":"Use of Dinitrophenol in Nutritional Disorders : A Critical Survey of Clinical Results","volume":"24","author":"Tainter","year":"1934","journal-title":"Am. J. Public Health Nations Health"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1056\/NEJM193409062111003","article-title":"Report of two cases of agranulocytosis following the use of dinitrophenol","volume":"211","author":"Dameshek","year":"1934","journal-title":"N. Engl. J. Med."},{"key":"ref_80","first-page":"405","article-title":"A Study of Dinitrophenol and Its Relation to Cataract Formation","volume":"39","author":"Horner","year":"1941","journal-title":"Trans. Am. Ophthalmol. Soc."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s13181-011-0162-6","article-title":"2,4-dinitrophenol (DNP): A weight loss agent with significant acute toxicity and risk of death","volume":"7","author":"Grundlingh","year":"2011","journal-title":"J. Med. Toxicol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1001\/jama.1934.02750140027011","article-title":"Sudden death from dinitrophenol poisoning report of a case with autopsy","volume":"102","author":"Poole","year":"1934","journal-title":"JAMA"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.yrtph.2007.03.006","article-title":"Dinitrophenol and obesity: An early twentieth-century regulatory dilemma","volume":"48","author":"Colman","year":"2007","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/191144a0","article-title":"Coupling of phosphorylation to electron and hydrogen transfer by a chemi-osmotic type of mechanism","volume":"191","author":"Mitchell","year":"1961","journal-title":"Nature"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"7180632","DOI":"10.1155\/2017\/7180632","article-title":"Mitochondrial Uncoupler Prodrug of 2,4-Dinitrophenol, MP201, Prevents Neuronal Damage and Preserves Vision in Experimental Optic Neuritis","volume":"2017","author":"Khan","year":"2017","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.expneurol.2017.03.020","article-title":"2,4 DNP Improves Motor Function, Preserves Medium Spiny Neuronal Identity, and Reduces Oxidative Stress in a Mouse Model of Huntington\u2019s disease","volume":"293","author":"Wu","year":"2017","journal-title":"Exp. Neurol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1111\/j.1471-4159.2005.03328.x","article-title":"The mitochondrial uncoupler 2,4-dinitrophenol attenuates tissue damage and improves mitochondrial homeostasis following transient focal cerebral ischemia","volume":"94","author":"Korde","year":"2005","journal-title":"J. Neurochem."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1089\/neu.2009.1189","article-title":"2,4-Dinitrophenol blocks neurodegeneration and preserves sciatic nerve function after trauma","volume":"27","author":"Martinez","year":"2010","journal-title":"J. Neurotrauma"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1042\/BJ20070606","article-title":"Mitochondrial uncouplers with an extraordinary dynamic range","volume":"407","author":"Lou","year":"2007","journal-title":"Biochem. J."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3390\/ph2030077","article-title":"A New Classification of Prodrugs: Regulatory Perspectives","volume":"2","author":"Wu","year":"2009","journal-title":"Pharmaceuticals"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/jps.23359","article-title":"The role of BCS (biopharmaceutics classification system) and BDDCS (biopharmaceutics drug disposition classification system) in drug development","volume":"102","author":"Benet","year":"2013","journal-title":"J. Pharm. Sci."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s40261-015-0354-y","article-title":"Lisdexamfetamine Dimesylate: Prodrug Delivery, Amphetamine Exposure and Duration of Efficacy","volume":"36","author":"Ermer","year":"2016","journal-title":"Clin. Drug Investig."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nrneurol.2014.24","article-title":"Huntington disease: Natural history, biomarkers and prospects for therapeutics","volume":"10","author":"Ross","year":"2014","journal-title":"Nat. Rev. Neurol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1212\/WNL.0b013e318249f683","article-title":"CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion","volume":"78","author":"Lee","year":"2012","journal-title":"Neurology"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/hmg\/8.3.397","article-title":"Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin","volume":"8","author":"Schilling","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/0024-3205(95)00055-B","article-title":"Bioenergetic and oxidative stress in neurodegenerative diseases","volume":"56","author":"Bowling","year":"1995","journal-title":"Life Sci."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1126\/science.7901908","article-title":"Oxidative stress, glutamate, and neurodegenerative disorders","volume":"262","author":"Coyle","year":"1993","journal-title":"Science"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3389\/fnagi.2014.00078","article-title":"Clinical and Biomarker Changes in Premanifest Huntington Disease Show Trial Feasibility: A Decade of the PREDICT-HD Study","volume":"6","author":"Paulsen","year":"2014","journal-title":"Front. Aging Neurosci."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jalz.2010.11.007","article-title":"National estimates of the prevalence of Alzheimer\u2019s disease in the United States","volume":"7","author":"Brookmeyer","year":"2011","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/978-1-4614-0653-2_16","article-title":"Mitochondrial importance in Alzheimer\u2019s, Huntington\u2019s and Parkinson\u2019s diseases","volume":"724","author":"Correia","year":"2012","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.nbd.2011.12.057","article-title":"Role of mitochondrial homeostasis and dynamics in Alzheimer\u2019s disease","volume":"51","author":"Selfridge","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"4183","DOI":"10.1523\/JNEUROSCI.21-12-04183.2001","article-title":"Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis","volume":"21","author":"Pratico","year":"2001","journal-title":"J. Neurosci."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1096\/fj.00-0676fje","article-title":"Inhibition of Alzheimer\u2019s disease beta-amyloid aggregation, neurotoxicity, and in vivo deposition by nitrophenols: Implications for Alzheimer\u2019s therapy","volume":"15","author":"Houzel","year":"2001","journal-title":"FASEB J."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"13548","DOI":"10.1038\/ncomms13548","article-title":"Defective mitochondrial DNA homeostasis in the substantia nigra in Parkinson disease","volume":"7","author":"Dolle","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/B978-0-444-63945-5.00017-9","article-title":"Prion-like propagation of pathology in Parkinson disease","volume":"153","author":"Brundin","year":"2018","journal-title":"Handb. Clin. Neurol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1111\/ejn.12459","article-title":"Time course of dopamine neuron loss and glial response in the 6-OHDA striatal mouse model of Parkinson\u2019s disease","volume":"39","author":"Stott","year":"2014","journal-title":"Eur. J. Neurosci."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.bbr.2015.03.058","article-title":"The 6-OHDA mouse model of Parkinson\u2019s disease\u2014Terminal striatal lesions provide a superior measure of neuronal loss and replacement than median forebrain bundle lesions","volume":"288","author":"Bagga","year":"2015","journal-title":"Behav. Brain Res."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/glia.23249","article-title":"Kallikrein 6 secreted by oligodendrocytes regulates the progression of experimental autoimmune encephalomyelitis","volume":"66","author":"Bando","year":"2018","journal-title":"Glia"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/ni1507","article-title":"Multiple sclerosis: A complicated picture of autoimmunity","volume":"8","author":"McFarland","year":"2007","journal-title":"Nat. Immunol."},{"key":"ref_110","first-page":"S13","article-title":"Pathogenesis of myelin\/oligodendrocyte damage in multiple sclerosis","volume":"68","year":"2007","journal-title":"Neurology"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.0105-2896.2005.00240.x","article-title":"Multiple sclerosis","volume":"204","author":"Hafler","year":"2005","journal-title":"Immunol. Rev."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.neurol.2018.03.007","article-title":"Atypical inflammatory demyelinating lesions and atypical multiple sclerosis","volume":"174","author":"Ayrignac","year":"2018","journal-title":"Rev. Neurol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/ana.20736","article-title":"Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients","volume":"59","author":"Dutta","year":"2006","journal-title":"Ann. Neurol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.neuint.2015.01.002","article-title":"Abnormal morphology of myelin and axon pathology in murine models of multiple sclerosis","volume":"81","author":"Bando","year":"2015","journal-title":"Neurochem. Int."},{"key":"ref_115","unstructured":"Zagon, I.S., and McLaughlin, P.J. (2017). Experimental In Vivo Models of Multiple Sclerosis: State of the Art. Multiple Sclerosis: Perspectives in Treatment and Pathogenesis, Codon Publications."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jneuroim.2016.08.007","article-title":"Effects of exercise on Irisin, BDNF and IL-6 serum levels in patients with progressive multiple sclerosis","volume":"299","author":"Briken","year":"2016","journal-title":"J. Neuroimmunol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1093\/brain\/awq179","article-title":"Functional role of brain-derived neurotrophic factor in neuroprotective autoimmunity: Therapeutic implications in a model of multiple sclerosis","volume":"133","author":"Linker","year":"2010","journal-title":"Brain"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"14182","DOI":"10.1523\/JNEUROSCI.6595-10.2011","article-title":"Levels of BDNF impact oligodendrocyte lineage cells following a cuprizone lesion","volume":"31","author":"VonDran","year":"2011","journal-title":"J. Neurosci."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1212\/WNL.45.2.244","article-title":"Optic neuritis: A population-based study in Olmsted County, Minnesota","volume":"45","author":"Rodriguez","year":"1995","journal-title":"Neurology"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.exer.2012.04.005","article-title":"In vivo detection of experimental optic neuritis by pupillometry","volume":"100","author":"Shindler","year":"2012","journal-title":"Exp. Eye Res."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"e135","DOI":"10.1212\/NXI.0000000000000135","article-title":"Acute optic neuritis: Unmet clinical needs and model for new therapies","volume":"2","author":"Galetta","year":"2015","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1056\/NEJM199802053380604","article-title":"Objective estimates of the probability of death from burn injuries","volume":"338","author":"Ryan","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1001\/jama.283.1.69","article-title":"Long-term outcome of children surviving massive burns","volume":"283","author":"Sheridan","year":"2000","journal-title":"JAMA"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1096\/fj.12-220764","article-title":"Mitochondria-targeted antioxidant promotes recovery of skeletal muscle mitochondrial function after burn trauma assessed by in vivo 31P nuclear magnetic resonance and electron paramagnetic resonance spectroscopy","volume":"27","author":"Righi","year":"2013","journal-title":"FASEB J."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1177\/0148607199023003160","article-title":"The metabolic basis of the increase of the increase in energy expenditure in severely burned patients","volume":"23","author":"Yu","year":"1999","journal-title":"J. Parenter. Enter. Nutr."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s10540-006-9018-8","article-title":"Targeting dinitrophenol to mitochondria: Limitations to the development of a self-limiting mitochondrial protonophore","volume":"26","author":"Blaikie","year":"2006","journal-title":"Biosci. Rep."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.neurol.2016.06.008","article-title":"Mechanical thrombectomy in acute ischemic stroke","volume":"173","author":"Derex","year":"2017","journal-title":"Rev. Neurol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1089\/neu.1998.15.789","article-title":"Traumatic brain injury alters synaptic homeostasis: Implications for impaired mitochondrial and transport function","volume":"15","author":"Sullivan","year":"1998","journal-title":"J. Neurotrauma"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1089\/neu.1997.14.23","article-title":"Mitochondrial dysfunction and calcium perturbation induced by traumatic brain injury","volume":"14","author":"Xiong","year":"1997","journal-title":"J. Neurotrauma"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.2174\/0929867033457160","article-title":"Cyclophilin D as a drug target","volume":"10","author":"Waldmeier","year":"2003","journal-title":"Curr. Med. Chem."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1006\/exnr.1999.7282","article-title":"Continuous infusion of cyclosporin A postinjury significantly ameliorates cortical damage following traumatic brain injury","volume":"161","author":"Sullivan","year":"2000","journal-title":"Exp. Neurol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1124\/mol.62.1.22","article-title":"Inhibition of the mitochondrial permeability transition by the nonimmunosuppressive cyclosporin derivative NIM811","volume":"62","author":"Waldmeier","year":"2002","journal-title":"Mol. Pharmacol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.4103\/1673-5374.235218","article-title":"Targeting the mitochondrial permeability transition pore in traumatic central nervous system injury","volume":"13","author":"Springer","year":"2018","journal-title":"Neural Regen. Res."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3389\/fnene.2013.00010","article-title":"Concentration dependent effect of calcium on brain mitochondrial bioenergetics and oxidative stress parameters","volume":"5","author":"Pandya","year":"2013","journal-title":"Front. Neuroenerget."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"617207","DOI":"10.1155\/2015\/617207","article-title":"Reactive oxygen species, apoptosis, and mitochondrial dysfunction in hearing loss","volume":"2015","author":"Kamogashira","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.mad.2010.04.006","article-title":"Mitochondrial oxidative damage and apoptosis in age-related hearing loss","volume":"131","author":"Someya","year":"2010","journal-title":"Mech. Ageing Dev."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/nrd.2016.222","article-title":"First hearing-disorder drugs stumble","volume":"15","author":"Kingwell","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_138","doi-asserted-by":"crossref","unstructured":"Gordon, J.S., Griest, S.E., Thielman, E.J., Carlson, K.F., Helt, W.J., Lewis, M.S., Blankenship, C., Austin, D., Theodoroff, S.M., and Henry, J.A. (2016). Audiologic characteristics in a sample of recently-separated military Veterans: The Noise Outcomes in Servicemembers Epidemiology Study (NOISE Study). Hear. Res.","DOI":"10.1016\/j.heares.2016.11.014"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s003359900748","article-title":"Molecular cloning of a novel mouse gene with predominant muscle and neural expression","volume":"9","author":"Geisler","year":"1998","journal-title":"Mamm. Genome"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0092-8674(87)90504-6","article-title":"Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals","volume":"50","author":"Koenig","year":"1987","journal-title":"Cell"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/0092-8674(87)90579-4","article-title":"Dystrophin: The protein product of the Duchenne muscular dystrophy locus","volume":"51","author":"Hoffman","year":"1987","journal-title":"Cell"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3390\/brainsci5030275","article-title":"Nonmechanical Roles of Dystrophin and Associated Proteins in Exercise, Neuromuscular Junctions, and Brains","volume":"5","author":"Nichols","year":"2015","journal-title":"Brain Sci."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/hmg\/dds415","article-title":"Defects in mitochondrial localization and ATP synthesis in the mdx mouse model of Duchenne muscular dystrophy are not alleviated by PDE5 inhibition","volume":"22","author":"Percival","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/hmg\/ddv460","article-title":"Effect of genetic background on the dystrophic phenotype in mdx mice","volume":"25","author":"Coley","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.2353\/ajpath.2010.090887","article-title":"Genetic background affects properties of satellite cells and mdx phenotypes","volume":"176","author":"Fukada","year":"2010","journal-title":"Am. J. Pathol."},{"key":"ref_146","doi-asserted-by":"crossref","unstructured":"Morine, K.J., Bish, L.T., Pendrak, K., Sleeper, M.M., Barton, E.R., and Sweeney, H.L. (2010). Systemic myostatin inhibition via liver-targeted gene transfer in normal and dystrophic mice. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0009176"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.nmd.2013.12.012","article-title":"Longitudinal measurements of MRI-T2 in boys with Duchenne muscular dystrophy: Effects of age and disease progression","volume":"24","author":"Willcocks","year":"2014","journal-title":"Neuromuscul. Disord."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1172\/JCI91445","article-title":"Intermittent glucocorticoid steroid dosing enhances muscle repair without eliciting muscle atrophy","volume":"127","author":"Quattrocelli","year":"2017","journal-title":"J. Clin. Investig."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0140-6736(17)32160-8","article-title":"Long-term effects of glucocorticoids on function, quality of life, and survival in patients with Duchenne muscular dystrophy: A prospective cohort study","volume":"391","author":"McDonald","year":"2018","journal-title":"Lancet"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"201696","DOI":"10.1155\/2011\/201696","article-title":"The recent understanding of the neurotrophin\u2019s role in skeletal muscle adaptation","volume":"2011","author":"Sakuma","year":"2011","journal-title":"J. Biomed. Biotechnol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1007\/s00380-018-1174-9","article-title":"Serum brain-derived neurotrophic factor level and exercise tolerance complement each other in predicting the prognosis of patients with heart failure","volume":"33","author":"Shibata","year":"2018","journal-title":"Heart Vessels"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1113\/EP086049","article-title":"Effects of exercise training on brain-derived neurotrophic factor in skeletal muscle and heart of rats post myocardial infarction","volume":"102","author":"Lee","year":"2017","journal-title":"Exp. Physiol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1249\/MSS.0b013e31821ece12","article-title":"2011 Compendium of Physical Activities: A second update of codes and MET values","volume":"43","author":"Ainsworth","year":"2011","journal-title":"Med. Sci. Sports Exerc."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1249\/00005768-199301000-00011","article-title":"Compendium of physical activities: Classification of energy costs of human physical activities","volume":"25","author":"Ainsworth","year":"1993","journal-title":"Med. Sci. Sports Exerc."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1210\/en.2012-1989","article-title":"Cellular mechanism by which estradiol protects female ovariectomized mice from high-fat diet-induced hepatic and muscle insulin resistance","volume":"154","author":"Camporez","year":"2013","journal-title":"Endocrinology"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1210\/en.2013-1191","article-title":"Cellular mechanisms by which FGF21 improves insulin sensitivity in male mice","volume":"154","author":"Camporez","year":"2013","journal-title":"Endocrinology"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.2337\/db08-1637","article-title":"Butyrate improves insulin sensitivity and increases energy expenditure in mice","volume":"58","author":"Gao","year":"2009","journal-title":"Diabetes"},{"key":"ref_158","doi-asserted-by":"crossref","unstructured":"Guo, J., and Hall, K.D. (2011). Predicting changes of body weight, body fat, energy expenditure and metabolic fuel selection in C57BL\/6 mice. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0015961"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.2337\/diabetes.51.7.2158","article-title":"Estrogen can prevent or reverse obesity and diabetes in mice expressing human islet amyloid polypeptide","volume":"51","author":"Geisler","year":"2002","journal-title":"Diabetes"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"603","DOI":"10.2337\/diabetes.54.3.603","article-title":"Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes","volume":"54","author":"Petersen","year":"2005","journal-title":"Diabetes"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.cmet.2013.12.008","article-title":"Fasting: Molecular mechanisms and clinical applications","volume":"19","author":"Longo","year":"2014","journal-title":"Cell Metab."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1001\/jama.1937.02780250024006","article-title":"Dinitrophenol and desiccated thyroid in the treatment of obesity","volume":"108","author":"Simkins","year":"1937","journal-title":"JAMA"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1172\/JCI115997","article-title":"Increased rate of gluconeogenesis in type II diabetes mellitus. A 13C nuclear magnetic resonance study","volume":"90","author":"Magnusson","year":"1992","journal-title":"J. Clin. Investig."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.cmet.2013.10.004","article-title":"Reversal of hypertriglyceridemia, fatty liver disease, and insulin resistance by a liver-targeted mitochondrial uncoupler","volume":"18","author":"Perry","year":"2013","journal-title":"Cell Metab."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1172\/JCI30400","article-title":"Inhibition of protein kinase Cepsilon prevents hepatic insulin resistance in nonalcoholic fatty liver disease","volume":"117","author":"Samuel","year":"2007","journal-title":"J. Clin. Investig."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1152\/physiol.00012.2016","article-title":"Physiological Aging: Links Among Adipose Tissue Dysfunction, Diabetes, and Frailty","volume":"32","author":"Stout","year":"2017","journal-title":"Physiology"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1126\/science.aaa0672","article-title":"Controlled-release mitochondrial protonophore reverses diabetes and steatohepatitis in rats","volume":"347","author":"Perry","year":"2015","journal-title":"Science"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.cmet.2012.08.012","article-title":"Energy intake and exercise as determinants of brain health and vulnerability to injury and disease","volume":"16","author":"Mattson","year":"2012","journal-title":"Cell Metab."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.arr.2012.01.007","article-title":"Evolutionary aspects of human exercise--born to run purposefully","volume":"11","author":"Mattson","year":"2012","journal-title":"Ageing Res. Rev."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.arr.2016.10.005","article-title":"Impact of intermittent fasting on health and disease processes","volume":"39","author":"Mattson","year":"2017","journal-title":"Ageing Res. Rev."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/acel.12527","article-title":"Caloric restriction increases brain mitochondrial calcium retention capacity and protects against excitotoxicity","volume":"16","author":"Amigo","year":"2017","journal-title":"Aging Cell"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.cell.2010.10.002","article-title":"Sirt3 mediates reduction of oxidative damage and prevention of age-related hearing loss under caloric restriction","volume":"143","author":"Someya","year":"2010","journal-title":"Cell"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"20","DOI":"10.2174\/1874609811003010020","article-title":"Effects of caloric restriction on age-related hearing loss in rodents and rhesus monkeys","volume":"3","author":"Someya","year":"2010","journal-title":"Curr. Aging Sci."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1046\/j.1528-1157.2001.17601.x","article-title":"Caloric restriction inhibits seizure susceptibility in epileptic EL mice by reducing blood glucose","volume":"42","author":"Greene","year":"2001","journal-title":"Epilepsia"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.mce.2017.01.042","article-title":"Nutrition and fasting mimicking diets in the prevention and treatment of autoimmune diseases and immunosenescence","volume":"455","author":"Choi","year":"2017","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.arr.2017.02.001","article-title":"Protective effects of short-term dietary restriction in surgical stress and chemotherapy","volume":"39","author":"Brandhorst","year":"2017","journal-title":"Ageing Res. Rev."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"5061","DOI":"10.1073\/pnas.88.11.5061","article-title":"cAMP response element-binding protein is activated by Ca2+\/calmodulin- as well as cAMP-dependent protein kinase","volume":"88","author":"Dash","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0896-6273(02)00828-0","article-title":"Function and regulation of CREB family transcription factors in the nervous system","volume":"35","author":"Lonze","year":"2002","journal-title":"Neuron"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1016\/j.bbadis.2014.07.012","article-title":"The role of soluble adenylyl cyclase in neurite outgrowth","volume":"1842","author":"Stiles","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev.pharmtox.41.1.145","article-title":"Regulation and role of adenylyl cyclase isoforms","volume":"41","author":"Hanoune","year":"2001","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.neuropharm.2013.01.011","article-title":"The role of phosphodiesterases in hippocampal synaptic plasticity","volume":"74","author":"Sanderson","year":"2013","journal-title":"Neuropharmacology"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cellsig.2017.11.004","article-title":"Cyclic nucleotide signaling changes associated with normal aging and age-related diseases of the brain","volume":"42","author":"Kelly","year":"2018","journal-title":"Cell Signal."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1096\/fj.04-1764com","article-title":"Targeting the neurotoxic species in Alzheimer\u2019s disease: Inhibitors of Abeta oligomerization","volume":"18","author":"Vieira","year":"2004","journal-title":"FASEB J."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"410","DOI":"10.5152\/tud.2017.66502","article-title":"Metabesity and urological cancers","volume":"43","author":"Atan","year":"2017","journal-title":"Turk. J. Urol."},{"key":"ref_185","first-page":"453","article-title":"Size at Birth and Later \u201cMetabesity\u201d","volume":"54","author":"Prabhakaran","year":"2017","journal-title":"Indian Pediatr."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1080\/15548627.2015.1009779","article-title":"Defects in calcium homeostasis and mitochondria can be reversed in Pompe disease","volume":"11","author":"Lim","year":"2015","journal-title":"Autophagy"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1750-1172-8-23","article-title":"Barth syndrome","volume":"8","author":"Clarke","year":"2013","journal-title":"Orphanet. J. Rare Dis."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1242\/dmm.030502","article-title":"Early cerebellar deficits in mitochondrial biogenesis and respiratory chain complexes in the KIKO mouse model of Friedreich ataxia","volume":"10","author":"Lin","year":"2017","journal-title":"Dis. Models Mech."},{"key":"ref_189","first-page":"E576","article-title":"Fat feeding causes widespread in vivo insulin resistance, decreased energy expenditure, and obesity in rats","volume":"251","author":"Storlien","year":"1986","journal-title":"Am. J. Physiol."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1463-1326.2006.00572.x","article-title":"Brain-derived neurotrophic factor enhances glucose utilization in peripheral tissues of diabetic mice","volume":"9","author":"Yamanaka","year":"2007","journal-title":"Diabetes Obes. Metab."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/jnc.12216","article-title":"Diabetes in Friedreich ataxia","volume":"126","author":"Cnop","year":"2013","journal-title":"J. Neurochem."},{"key":"ref_192","first-page":"3029","article-title":"MeCP2 co-ordinates liver lipid metabolism with the NCoR1\/HDAC3 corepressor complex","volume":"25","author":"Kyle","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1001\/archneur.65.4.476","article-title":"Glucose homeostasis in Huntington disease: Abnormalities in insulin sensitivity and early-phase insulin secretion","volume":"65","author":"Lalic","year":"2008","journal-title":"Arch. Neurol."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3389\/fphys.2014.00231","article-title":"Metabolic and hormonal signatures in pre-manifest and manifest Huntington\u2019s disease patients","volume":"5","author":"Wang","year":"2014","journal-title":"Front. Physiol."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/8\/3\/280\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:40:13Z","timestamp":1760186413000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/8\/3\/280"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,23]]},"references-count":194,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,3]]}},"alternative-id":["cells8030280"],"URL":"https:\/\/doi.org\/10.3390\/cells8030280","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,23]]}}}